More importantly, the PLS-123′s potent efficacy against B-cell lymphoma might be attributed to effective apoptosis induction, dual-action Btk inhibitory mode and alternative selectivity profile offered additional anti-tumor mechanism. Here, BTK is linked to B-cell non-Hodgkin lymphoma.